FDA Approves First-Ever Drug for Serious Liver Condition

(MedPage Today) -- The FDA granted accelerated approval to resmetirom (Rezdiffra) as the first treatment for adults with noncirrhotic non-alcoholic steatohepatitis (NASH), also now referred to as metabolic dysfunction-associated steatohepatitis...
Source: MedPage Today Public Health - Category: American Health Source Type: news